Shiraz E-Medical Journal

Published by: Kowsar
Crossmark

Hepatitis B Virus Infection Serology and the Associated Risk Factors Among Patients With HIV in Shiraz, Iran

Mohammad Ali Davarpanah 1 , Nasrin Motazedian 1 , * , Ebrahim Fallahzadeh 2 , Maryam Rasti 2 , Hashem Rahmati 3 and Nadia Motazedian 1
Authors Information
1 Shiraz HIV/AIDS Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Faculty of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Shiraz E-Medical Journal: April 01, 2015, 16 (4); e24676
  • Published Online: April 23, 2015
  • Article Type: Research Article
  • Received: October 18, 2014
  • Revised: January 3, 2015
  • Accepted: January 9, 2015
  • DOI: 10.17795/semj24676

To Cite: Davarpanah M A, Motazedian N, Fallahzadeh E, Rasti M, Rahmati H, et al. Hepatitis B Virus Infection Serology and the Associated Risk Factors Among Patients With HIV in Shiraz, Iran, Shiraz E-Med J. 2015 ; 16(4):e24676. doi: 10.17795/semj24676.

Abstract
Copyright © 2015, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology. 2009; 49(5 Suppl)-45[DOI][PubMed]
  • 2. Chen JJ, Yu CB, Du WB, Li LJ. Prevalence of hepatitis B and C in HIV-infected patients: a meta-analysis. Hepatobiliary Pancreat Dis Int. 2011; 10(2): 122-7[PubMed]
  • 3. Hou J, Liu Z, Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci. 2005; 2(1): 50-7[PubMed]
  • 4. Chun HM, Fieberg AM, Hullsiek KH, Lifson AR, Crum-Cianflone NF, Weintrob AC, et al. Epidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years. Clin Infect Dis. 2010; 50(3): 426-36[DOI][PubMed]
  • 5. Kim JH, Psevdos G, Suh J, Sharp VL. Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States. World J Gastroenterol. 2008; 14(43): 6689-93[PubMed]
  • 6. Adekunle AE, Oladimeji AA, Temi AP, Adeseye AI, Akinyeye OA, Taiwo RH. Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria. Pan Afr Med J. 2011; 9: 6[PubMed]
  • 7. Patel P, Davis S, Tolle M, Mabikwa V, Anabwani G. Prevalence of hepatitis B and hepatitis C coinfections in an adult HIV centre population in Gaborone, Botswana. Am J Trop Med Hyg. 2011; 85(2): 390-4[DOI][PubMed]
  • 8. Mendes-Correa MC, Pinho JR, Gomes-Gouvea MS, da Silva AC, Guastini CF, Martins LG, et al. Predictors of HBeAg status and hepatitis B viraemia in HIV-infected patients with chronic hepatitis B in the HAART era in Brazil. BMC Infect Dis. 2011; 11: 247[DOI][PubMed]
  • 9. Alavi SM, Etemadi A. HIV/HBV, HIV/HCV and HIV/HTLV-1 co infection among injecting drug user patients hospitalized at the infectious disease ward of a training hospital in Iran. Pak J Med Sci. 2007; 23(4): 510-3
  • 10. Ramezani A, Mohraz M, Gachkar L. Epidemiologic situation of human immunodeficiency virus (HIV/AIDS patients) in a private clinic in Tehran, Iran. Arch Iran Med. 2006; 9(4): 315-8[PubMed]
  • 11. Perez-Rodriguez MT, Sopena B, Crespo M, Rivera A, Gonzalez del Blanco T, Ocampo A, et al. Clinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patients. World J Gastroenterol. 2009; 15(10): 1237-41[PubMed]
  • 12. Santos EA, Yoshida CF, Rolla VC, Mendes JM, Vieira IF, Arabe J, et al. Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis. 2003; 22(2): 92-8[DOI][PubMed]
  • 13. Ramezani A, Banifazl M, Eslamifar A, Aghakhani A. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries. 2010; 4(10): 658-61[PubMed]
  • 14. Gupta S, Singh S. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India. BMC Infect Dis. 2010; 10: 53[DOI][PubMed]
  • 15. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 16. Mohammadi M, Talei G, Sheikhian A, Ebrahimzade F, Pournia Y, Ghasemi E, et al. Survey of both hepatitis B virus (HBsAg) and hepatitis C virus (HCV-Ab) coinfection among HIV positive patients. Virol J. 2009; 6: 202[DOI][PubMed]
  • 17. Mohammad Nejad E, Ehsani SR, Rabirad N, Deljo R, Ranjbarn S, Rezaee S, et al. Prevalence of HBV in HIV Patients Referred to Imam Khomeini Hospital, Tehran, Iran from 2008-2010. Iran Red Crescent Med J. 2013; 15(4): 379-80[DOI][PubMed]
  • 18. Keramat F, Eini P, Majzoobi MM. Seroprevalence of HIV, HBV and HCV in Persons Referred to Hamadan Behavioral Counseling Center, West of Iran. Iran Red Crescent Med J. 2011; 13(1): 42-6[PubMed]
  • 19. Vaziri S, Mansouri F, Sayad B, Afsharian M, Janbakhsh A, Karami M. Hepatitis D virus infection among HIV-HBV co-infected patients in Kermanshah, West of Iran. Hepat Mon. 2008; 8(4): 252-7
  • 20. He N, Chen L, Lin HJ, Zhang M, Wei J, Yang JH, et al. Multiple viral coinfections among HIV/AIDS patients in China. Biosci Trends. 2011; 5(1): 1-9[PubMed]
  • 21. Todd CS, Abed AM, Strathdee SA, Scott PT, Botros BA, Safi N, et al. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis. 2007; 13(9): 1327-31[DOI][PubMed]
  • 22. Adoga MP, Banwat EB, Forbi JC, Nimzing L, Pam CR, Gyar SD, et al. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. J Infect Dev Ctries. 2009; 3(7): 539-47[PubMed]
  • 23. Jobarteh M, Malfroy M, Peterson I, Jeng A, Sarge-Njie R, Alabi A, et al. Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians. Virol J. 2010; 7: 230[DOI][PubMed]
  • 24. Sheng WH, Kao JH, Chen PJ, Huang LM, Chang SY, Sun HY, et al. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2007; 45(9): 1221-9[DOI][PubMed]
  • 25. Zago AM, Machado TF, Cazarim FL, Miranda AE. Prevalence and risk factors for chronic hepatitis B in HIV patients attended at a sexually-transmitted disease clinic in Vitoria, Brazil. Braz J Infect Dis. 2007; 11(5): 475-8[PubMed]
  • 26. Ranjbar R, Davari A, Izadi M, Jonaidi N, Alavian SM. HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article. Iran Red Crescent Med J. 2011; 13(12): 855-62[PubMed]
  • 27. Lada O, Benhamou Y, Poynard T, Thibault V. Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants. J Virol. 2006; 80(6): 2968-75[DOI][PubMed]
  • 28. Liu W, Hu T, Wang X, Chen Y, Huang M, Yuan C, et al. Coexistence of hepatitis B surface antigen and anti-HBs in Chinese chronic hepatitis B virus patients relating to genotype C and mutations in the S and P gene reverse transcriptase region. Arch Virol. 2012; 157(4): 627-34[DOI][PubMed]
  • 29. Ramezani A, Banifazl M, Mohraz M, Rasoolinejad M, Aghakhani A. Occult hepatitis B virus infection: A major concern in HIV-infected patients: Occult HBV in HIV. Hepat Mon. 2011; 11(1): 7-10[PubMed]
  • 30. Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis. 1998; 17(1): 6-13[PubMed]
  • 31. Alavian SM. Ministry of Health in Iran is serious about controlling hepatitis B. Hepat Mon. 2007; 7(1): 3-5
  • 32. Tahaei SME, Mohebbi SR, Azimzadeh P, Vahedi M, Almasi S, Romani S, et al. Frequency of HIV and HCV Co-Infections in Chronic HBV Patients Referred to Taleghani Hospital, Tehran, Iran from 2006 to 2010. Hepat Mon. 2011; 11(12): 993-6[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments